Literature DB >> 16256258

Prevalence of clinical vaginal candidiasis in a university hospital and possible risk factors.

Odysseas Grigoriou1, Stavroula Baka, Evangelos Makrakis, Dimitrios Hassiakos, George Kapparos, Evangelia Kouskouni.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the prevalence of symptomatic vaginal candidiasis and probable predisposing factors in a university-based hospital. STUDY
DESIGN: A total of 576 cases of clinical vaginal candidiasis were enrolled in this survey and wet mount preparations, Gram-stained smears and vaginal cultures were assessed. Possible risk factors, such as pregnancy, diabetes mellitus, contraceptive and antibiotic use were evaluated.
RESULTS: Clinical vaginal candidiasis was detected in 12.1% of the cases. Candida albicans was isolated in 80.2% of patients and non-albicans species in 19.8%. Pruritus was the most common symptom (85.9%), followed by vaginal discharge (66.1%), soreness (31.1%) and dyspareunia (5.0%). Reproductive age, pregnancy, diabetes, contraception as well as recent antibiotic use correlated positively with both C. albicans and non-albicans isolates. Soreness and dyspareunia were significantly related to non-albicans species. The overall recurrence rate was 8.5%. Recurrences correlated positively to non-albicans infections.
CONCLUSIONS: C. albicans was, by far, the predominant yeast isolate. Non-albicans isolates caused significantly more frequent soreness, dyspareunia and recurrences than C. albicans. Clinical and laboratory findings, together with possible predisposing factors must be taken into consideration in order to achieve appropriate treatment.

Entities:  

Mesh:

Year:  2005        PMID: 16256258     DOI: 10.1016/j.ejogrb.2005.09.015

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  27 in total

1.  Risk factors for candida infection of the genital tract in the tropics.

Authors:  Na Dou; Weiping Li; Enfeng Zhao; Chan Wang; Zhaozhao Xiao; Honghui Zhou
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

2.  Vulvovaginal Candidiasis Caused by Non-albicans Candida Species: New Insights.

Authors:  Melissa A Kennedy; Jack D Sobel
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

3.  Comparison of the therapeutic effects of Garcin(®) and fluconazole on Candida vaginitis.

Authors:  Farzaneh Ebrahimy; Mahrokh Dolatian; Fariborz Moatar; Hamid Alavi Majd
Journal:  Singapore Med J       Date:  2015-10       Impact factor: 1.858

4.  An estimate of the burden of serious fungal diseases in Greece.

Authors:  M N Gamaletsou; M Drogari-Apiranthitou; D W Denning; N V Sipsas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-16       Impact factor: 3.267

5.  An evaluation of risk factors in pregnant women with Candida vaginitis and the diagnostic value of simultaneous vaginal and rectal sampling.

Authors:  Ahmet Barış Guzel; Macit Ilkit; Refik Burgut; Ibrahim Ferhat Urunsak; Fatma Tuncay Ozgunen
Journal:  Mycopathologia       Date:  2011-02-04       Impact factor: 2.574

6.  Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study.

Authors:  B Minea; V Nastasa; R F Moraru; A Kolecka; M M Flonta; I Marincu; A Man; F Toma; M Lupse; B Doroftei; N Marangoci; M Pinteala; T Boekhout; M Mares
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-09-16       Impact factor: 3.267

7.  Comparative risk of genital infections associated with sodium-glucose co-transporter-2 inhibitors.

Authors:  Chintan V Dave; Sebastian Schneeweiss; Elisabetta Patorno
Journal:  Diabetes Obes Metab       Date:  2018-10-11       Impact factor: 6.577

8.  Chlorhexidine, clotrimazole, metronidazole and combination therapy in the treatment of vaginal infections.

Authors:  Shahla Mirzaeei; Maryam Zangeneh; Firoozeh Veisi; Somayeh Parsa; Maryam Hematti
Journal:  J Med Life       Date:  2021 Mar-Apr

9.  Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam.

Authors:  Do Ngoc Anh; Dao Nguyen Hung; Tran Viet Tien; Vu Nhat Dinh; Vu Tung Son; Nguyen Viet Luong; Nguyen Thi Van; Nguyen Thi Nhu Quynh; Nguyen Van Tuan; Le Quoc Tuan; Nguyen Duy Bac; Nguyen Khac Luc; Le Tran Anh; Do Minh Trung
Journal:  BMC Infect Dis       Date:  2021-06-03       Impact factor: 3.090

10.  Hosting infection: experimental models to assay Candida virulence.

Authors:  Donna M Maccallum
Journal:  Int J Microbiol       Date:  2011-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.